If you’re a woman, there’s a good chance you’ve used Johnson’s Baby Powder at some point. It smells good, and it can keep you dry.
But is it dangerous?
Dr. Daniel Cramer says yes. He’s a professor of obstetrics and … Read more
On August 17, 2017, the U.S. Food and Drug Administration (FDA) granted regular approval to olaparib tablets (Lynparza) for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, who are in a complete … Read more
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to … Read more
By: Kelly Irvin
I’m a life-long writer with a degree in journalism, 40 years of nonfiction writing experience, 12 published novels and three novellas to my name. Words are of paramount importance to me. They are powerful weapons mightier than … Read more
In an effort to better group tumors into relevant targetable populations, investigators recently evaluated 4114 ovarian tumor specimens to identify the different molecular changes that can occur within the specimens, according to lead investigator, Julia A. Elvin, MD, PhD.
According … Read more
Patients who expressed a specific tumor antigen had more aggressive cancers and were more likely to die early from their disease, according to a large study conducted by Roswell Park Cancer Institute researchers and published in the journal Gynecologic Oncology.… Read more
A pair of UC Riverside researchers say they have found a mechanism for blocking the spread of ovarian cancer, one of the deadliest cancers for women.
Recent University of Notre Dame transplants Mark Alber and Oleg Kim, along with a … Read more
Pathologists and oncologists work closely together to treat patients with cancer, and will continue to do so as more individualized treatments become popular. In ovarian cancer, tumors evolve over time, making this relationship between members of the treatment team even … Read more
One of the great traits of Coronado resident Peg Ford, is her indomitable spirit. The Toronto, Canada native is approaching her 50th year living in the United States and holds dual citizenship in the two nations. A survivor of Stage … Read more
For many women, by the time ovarian cancer symptoms appear, the disease has spread. Late detection will contribute to more than 14,000 women losing their lives this year, and fewer than half will survive five years after diagnosis.
As a … Read more
PARP inhibitor Lynparza (olaparib) has been embraced by oncologists treating women with BRCA-mutant ovarian cancer, and the AstraZeneca drug is also showing promise in breast cancers that harbor the same mutations. But scientists led by the University of Pennsylvania believe … Read more
By: Annette McElhiney
On July 29, 2017, I celebrated 9 years since my IIIC ovarian cancer debulking surgery. Because I’ve been so fortunate to be in remission, I spend hours each day researching, writing, and corresponding with other ovarian cancer … Read more
By: Susan Gubar
Many people associate palliative care with hospice care, but medical professionals are offering it to children and adolescents living with cancer as well as to those dying from it.
In the process, they are redefining both palliative … Read more
It is difficult for advances to be made in rare cancers because there are fewer patients. This makes it more challenging to conduct clinical trials for these diseases. Rare ovarian cancers are no exception to this.
In an interview with … Read more
Pam Kusar thought she had “GHD gut.” Or worse.
Anyone who’s done GHD sit-ups after a reprieve from the movement knows the feeling—getting out of bed, sneezing, laughing, crying all induce pain, if you’ve done more reps than you should … Read more
Researchers at the UC San Diego School of Medicine were awarded $5.8 million Thursday to develop an immunotherapy that would target certain cancer stem cells.
The grant from the California Institute for Regenerative Medicine’s Independent Citizens Oversight Committee addresses cancers … Read more
The protein CA125, which is commonly expressed on the surface of ovarian cancer cells and is secreted into the bloodstream, was found to block the activity of investigational drug farletuzumab. Farletuzumab is currently in clinical development for the treatment of … Read more
Mutations in the BRCA gene correspond to a higher lifetime risk of developing breast and ovarian cancers, and many women who carry these mutations consider undergoing mastectomy or removal of the ovaries and fallopian tubes as preventive measures.
But for
… Read moreToward the end of the great adventure movie “A High Wind in Jamaica,” a gang of pirates is sentenced to hang for a murder they didn’t commit.
“I don’t want to die innocent!” a crewman cries out to his captaI … Read more
Starting
January 1, 2025,
Clearity is joining
Ovarian Cancer
Research Alliance
(OCRA) and this website
will be redirected to
www.ocrahope.org
OCRA and Clearity are committed to serving the ovarian cancer community and providing the education, information, and support people need.
